PEDIATRIC DRUGS

Abbr. PEDIATR DRUGS ·NEW ZEALAND ·Avg. articles/yr 42 articles

3.3

Latest IF

1.00%

Self-citation

较易

Submission difficulty

>12周，或约稿

Review cycle

About Journal

PEDIATRIC DRUGS是一本专注于儿科药物研究的国际期刊，ISSN号为1174-5878，由Adis International Ltd出版，出版地为新西兰，出版周期为双月刊。该期刊的影响因子根据年份有所不同，最新数据需查阅JCR报告，目前为非开放获取（非OA）期刊，被SCI收录，中科院分区情况需根据最新分区表确认。杂志的发文特点集中于儿科药物治疗、临床药理学、药物安全性及疗效评估等领域，旨在为儿科医学和药学研究者提供高质量的学术交流平台。其研究领域涵盖新生儿至青少年阶段的药物开发、合理用药及循证医学研究。杂志的质量较高，审稿严格，但作为专业期刊，读者群体相对局限，可能存在投稿竞争激烈或审稿周期较长的风险。总体而言，PEDIATRIC DRUGS是儿科药学领域的重要期刊，适合相关领域的研究者关注和投稿。

IF Trend

Recent Articles

Current Management and Emerging Therapies for Pediatric Vitiligo: A Narrative Review 2026-09-22

Repeated-Dose High-Dose Ivermectin Pharmacokinetics and Safety in Children with Acute Dengue 2026-09-22

Real-World Outcomes of Ocrelizumab and Ofatumumab Treatment in Pediatric-Onset Multiple Sclerosis 2026-09-21

Managing Sjögren’s Disease in Pediatric Patients 2026-09-21

Authors' Reply to Kaplan Comment on “Safety and Efficacy of Oral Ferric Maltol and Ferrous Sulfate for Iron Deficiency Anemia in Infants, Children and Adolescents: A Multicenter Randomized Trial” 2026-09-18

Comment on “Safety and Efficacy of Oral Ferric Maltol and Ferrous Sulfate for Iron Deficiency Anemia in Infants, Children and Adolescents: A Multicenter Randomized Trial” 2026-09-18

How Organ Manifestations Beyond the Bone May Guide Risk Stratification and Treatment Decisions in Chronic Nonbacterial Osteomyelitis 2026-09-15

Model-Informed Precision Dosing in Pediatric Patients: Current Software Tools and Bedside Guided Application 2026-08-21

AFREZZA® (Insulin Human) Inhalation Powder: Pediatric First Approval 2026-08-18

Novel Agents on the Therapeutic Horizon For Paediatric Inflammatory Bowel Diseases: An Analysis of Clinical Trials Registries 2026-08-13